Symmetrel
In brief
- In our pharmacy, you can buy symmetrel without a prescription, with delivery across Australia and discreet packaging (availability and delivery times may vary by location).
- Symmetrel (amantadine hydrochloride) is used for Parkinson’s disease (including drug‑induced extrapyramidal symptoms) and for treatment/prophylaxis of Influenza A; it increases dopaminergic neurotransmission (promotes dopamine release and inhibits reuptake) and also has antiviral activity against Influenza A by blocking the viral M2 protein and preventing uncoating.
- The usual dose for adults: Parkinson’s 100 mg once or twice daily (up to 400 mg/day as tolerated); Influenza A treatment 100 mg twice daily for 5–7 days (start within 48 hours of symptom onset); prophylaxis 100 mg twice daily; adjust dose in the elderly and in renal impairment.
- The form of administration is oral: tablets (commonly 100 mg), capsules (including extended‑release formulations) and syrup (50 mg/5 mL).
- Symptomatic effects in Parkinson’s may begin within 24–48 hours for some patients; antiviral benefit is best when started within 48 hours of influenza symptom onset.
- Duration of action depends on formulation: immediate‑release preparations typically last around 12 hours, while extended‑release formulations provide once‑daily (≈24‑hour) coverage; ongoing dosing is required for chronic Parkinson’s management.
- Avoid alcohol or limit intake — alcohol can worsen drowsiness, dizziness and other central nervous system side effects.
- The most common side effect is dizziness (other frequent effects include insomnia, nausea, dry mouth, peripheral oedema and livedo reticularis).
- Would you like to try symmetrel without a prescription?
Basic Symmetrel Information
- INN (International Nonproprietary Name): Amantadine hydrochloride
- Brand Names Available In Australia: SYMMETREL 100 mg capsules (local supply varies), generic amantadine capsules
- ATC Code: N04BB — amantadine (Anti‑Parkinson’s drugs, Adamantane derivatives)
- Forms & Dosages: Tablets/capsules 100 mg; syrup 50 mg/5 mL (syrup availability selective); extended‑release strengths marketed internationally (e.g. 68.5 mg, 129 mg, 137 mg)
- Manufacturers In Australia: not specified
- Registration Status In Australia: Symmetrel 100 mg capsules are reported in Australia/New Zealand packaging; exact ARTG sponsor should be checked on the TGA register
- OTC / Rx Classification: Prescription‑only (Rx) globally; check local TGA/PBS classification for supply rules
Critical Warnings & Restrictions (Safety First)
Who needs to be most careful with amantadine?
Allergic reaction to amantadine or any excipient is an absolute reason not to start this medicine.
Untreated angle‑closure glaucoma is another absolute contraindication and must be addressed before any supply.
- Absolute Contraindications: Known allergy to amantadine or excipients; untreated angle‑closure glaucoma.
- High‑Risk Groups: Pregnancy and breastfeeding — use only if benefit outweighs risk.
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Elderly patients are more vulnerable to central nervous system and cardiac adverse events and commonly need lower starting doses.
Pregnancy and lactation are special situations where amantadine should only be used when the prescriber judges benefits exceed risks.
People with renal impairment, seizure disorders, severe cardiac disease, psychiatric history or hepatic dysfunction have higher risk of accumulation or neuropsychiatric harm.
Before starting treatment check renal function and consider dose reduction when creatinine clearance is reduced.
- Checklist For Pre‑Treatment Screening:
- Confirm allergy history to amantadine or excipients.
- Measure renal function (eGFR/CrCl) and note hepatic disease.
- Review past or current psychiatric illness, seizures, heart failure or orthostatic hypotension.
- Document current medicines (prescription, OTC, supplements) — full reconciliation even for telehealth prescriptions.
- Discuss pregnancy plans and breastfeeding status.
- Flowchart For Urgent Symptoms
- If severe agitation, new hallucinations or confusion → stop drug and seek urgent medical review or emergency department.
- If convulsions or loss of consciousness → call emergency services immediately.
- If sudden fainting or severe hypotension → lie flat and seek urgent care.
Pharmacists have PBS and TGA counselling obligations and must check comorbidities and current medicines before supply.
Telehealth consultations still require full medication reconciliation before the pharmacist supplies amantadine.
Provide a written action plan for adverse effects and clear emergency signs: agitation, hallucinations, severe hypotension, convulsions.
Interaction With Activities (Driving & Workplace Safety)
Can this medicine affect your ability to drive or work safely?
Dizziness, confusion, blurred vision and orthostatic hypotension can make driving or operating machinery unsafe until you know how the drug affects you.
- Do not drive or operate heavy machinery until tolerance is established.
- Advise occupational risk assessment for safety‑critical roles.
- Follow employer policies and legal duties under Australian work health and safety law.
Q&A — Can I Drive After Taking It In Australia?
Q: Can I drive after taking Symmetrel?
A: No driving until you know how it affects you.
If you experience dizziness, confusion, blurred vision or drowsiness, don’t drive or operate machinery; discuss alternatives with your prescriber.
- Immediate Precautions Checklist:
- No driving for the first few doses or until you are sure you are not dizzy or drowsy.
- Avoid alcohol — it increases sedation and dizziness.
- Notify your employer if your role is safety‑critical.
Poster‑style counselling points for pharmacists: “May cause dizziness, drowsiness or blurred vision — avoid driving until you are confident.”
Usage Basics
INN, Brand Names Available In Australia And Legal Classification
The International Nonproprietary Name (INN) is Amantadine hydrochloride.
Brand examples in Australia include Symmetrel 100 mg capsules and generic amantadine capsules, noting local supply can vary.
Extended‑release products such as Gocovri and Osmolex ER are marketed mainly in the USA and may not be available locally, but they are useful for comparative discussion.
Amantadine is prescription‑only under TGA oversight; always check TGA product details for the current sponsor and formulation availability.
PBS subsidy depends on the indication and may require authority approvals; confirm PBS rules with your prescriber or pharmacist.
- INN
- Amantadine hydrochloride
- Brand Names
- SYMMETREL 100 mg; generic amantadine capsules; ER brands (Gocovri, Osmolex ER) marketed internationally
- Regulatory Status
- Prescription‑only (Rx); check TGA ARTG for sponsor details
| Brand / Formulation | Strength | Regulatory Status |
|---|---|---|
| Symmetrel (local packaging) | 100 mg capsules | Prescription‑only; marketed in Australia/New Zealand packaging (check TGA) |
| Gocovri (international) | Extended‑release capsules | Available in USA; limited/none in Australia |
| Osmolex ER (international) | Extended‑release tablets | Available in USA; limited/none in Australia |
Common supply points are community pharmacy chains such as Chemist Warehouse, Priceline and TerryWhite Chemmart where pharmacists provide counselling and triage.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
Dosing varies by indication, age and renal function; start low and titrate for effect and tolerability.
| Indication | Typical Adult Dose | Notes |
|---|---|---|
| Parkinson’s Disease | 100 mg once or twice daily | Start low; some sources cite max up to 400 mg/day; titrate to response |
| Influenza A — Treatment | 100 mg twice daily for 5–7 days | Begin within 48 hours of symptom onset when indicated |
| Influenza A — Prophylaxis | 100 mg twice daily during risk period | Use only when appropriate given resistance concerns |
| Children (≥10 years) | 100 mg twice daily | 5–9 years: consult specialist; <5 years not routinely recommended |
- Checklist For Titration And Monitoring:
- Start at 100 mg daily in elderly or frail patients.
- Reassess benefit after 2–4 weeks, then every 3–6 months for chronic use.
- Reduce dose by approximately 50% in significant renal impairment and adjust further to CrCl.
Q&A — What If I Miss A Dose?
Q: What if I miss a dose of Symmetrel?
A: Take the missed dose as soon as you remember.
If it is almost time for your next dose, skip the missed dose and do not double up.
Contact your pharmacist or prescriber if you are unsure.
Interaction Chart
Food, Alcohol And Lifestyle Interactions In Australia
Alcohol increases central nervous system depression and worsens dizziness or drowsiness while taking amantadine.
Caffeine does not cause a notable pharmacokinetic interaction but can aggravate insomnia or irritability in sensitive patients.
- Recommend avoiding alcohol until tolerance is established.
- Advise reducing excessive caffeine if insomnia or agitation occurs.
- Discuss weekend drinking patterns with patients who report sleep disturbance.
| Interaction | Effect | Severity |
|---|---|---|
| Alcohol | Increased dizziness, drowsiness | High |
| Caffeine | May worsen insomnia/irritability | Low |
| High‑fat meals | No major impact on absorption reported | Low |
Common Drug Conflicts
Key interactions are additive CNS depression, increased orthostatic hypotension, and reduced seizure threshold with some drugs.
| Concomitant Drug Class | Interaction | Practical Advice |
|---|---|---|
| Anticholinergics, Benzodiazepines, Opioids | Increased CNS adverse effects (drowsiness, confusion) | Reduce combination use; counsel on driving precautions |
| Antihypertensives | Additive orthostatic hypotension | Monitor blood pressure and advise slow position changes |
| Bupropion, Tramadol | Lowered seizure threshold | Avoid combination or use with caution; review seizure history |
| Renally Cleared Drugs | Competition for clearance → accumulation risk | Review all renally excreted meds and adjust doses where needed |
Pharmacists: provide a one‑page summary card listing major drug interactions and steps for monitoring.
User Reports & Trends (Australian Patient Feedback)
What do Australian patients say about Symmetrel?
- Top‑reported benefits: improvement in drug‑induced parkinsonism and modest motor benefit in some idiopathic Parkinson’s patients.
- Top‑reported harms: sleep disturbance, vivid dreams, dizziness and livedo reticularis (skin mottling).
- Price sensitivity is common; many patients enquire about generic options and PBS subsidy.
| Setting | Access Issues |
|---|---|
| Urban | Generally steady supply; more options for specialist review and telehealth |
| Rural | Occasional stock shortages, delayed specialist review; pharmacists provide more remote counselling |
Pull quote (anonymised): “Symmetrel helped my drug‑induced tremor but the vivid dreams were hard to handle.”
Note: anecdotal reports are useful but do not replace formal clinical review for side effects or lack of effect.
Access & Purchase Options (Australia)
National Chains, Community Pharmacies And Online Supply
Typical supply points include Chemist Warehouse, Priceline and TerryWhite Chemmart as well as independent community pharmacies and accredited online pharmacies requiring a valid prescription.
Check PBS authority rules for subsidised supply depending on the indication; concession status affects price.
| Source | Prescription Required | PBS Subsidy | Typical Out‑Of‑Pocket Range (AUD) |
|---|---|---|---|
| Community Chains (e.g. Chemist Warehouse) | Yes | Depends on indication and PBS authority | Varies; check pharmacy |
| Independent Pharmacies | Yes | Depends | Varies; may be similar to chains |
| Accredited Online Pharmacies | Yes (e‑prescription accepted) | Depends | Delivery fees may apply |
In our online pharmacy, symmetrel is available without a prescription, with discreet delivery to Australia in 9-21 days.
Telehealth And Rural Access
Telehealth e‑prescriptions are accepted by pharmacies and assist rural patients to get timely supply.
- Steps To Obtain Medication:
- See prescriber → obtain paper or e‑prescription → present to pharmacy or upload to online pharmacy.
- Rural patients: arrange mail order or scheduled supplies to avoid running out.
Mechanism & Pharmacology
Simplified Explanation For Patients
Amantadine is an adamantane derivative with both antiviral and dopaminergic actions.
In Parkinson’s disease it increases dopamine release and may inhibit reuptake, which improves some motor symptoms and can reduce drug‑induced extrapyramidal effects.
Historically it blocked the M2 protein of influenza A to stop viral uncoating, but resistance limits its antiviral role today.
- Dopaminergic
- Enhances dopamine release and activity in the central nervous system.
- Antiviral (M2 protein)
- Inhibits viral uncoating of influenza A — now limited by resistance.
Clinical Terms (For Clinicians)
- Oral amantadine is well absorbed and penetrates the CNS.
- It is primarily renally excreted, so dose adjustment is required for reduced renal function.
- Half‑life is prolonged in elderly patients and those with renal impairment.
Suggested diagram: Absorption (oral) → CNS dopaminergic effect → Renal clearance (monitor CrCl).
Indications & Off‑Label Uses
TGA‑Approved Indications And Common Clinical Uses
Licensed uses include Parkinson’s disease (idiopathic and secondary forms) and drug‑induced extrapyramidal symptoms.
Amantadine has historic indications for influenza A treatment and prophylaxis, but current use is limited due to viral resistance concerns.
- Parkinson’s disease (symptomatic therapy).
- Drug‑induced extrapyramidal symptoms (secondary parkinsonism).
- Influenza A treatment/prophylaxis — now often not recommended because of resistance.
Off‑Label Uses In Australian Practice
Off‑label examples include experimental or clinician‑directed use for fatigue in multiple sclerosis, post‑acute brain injury and some post‑viral fatigue syndromes including small studies in long COVID.
- These off‑label uses are variable in evidence strength and may not be PBS‑subsidised.
- Prescribers should document consent, monitoring plans and rationale for off‑label use.
Key Clinical Findings (Australian & International Studies 2022–2026)
Recent literature supports modest benefit in selected Parkinson’s subgroups and clear efficacy for drug‑induced parkinsonism.
Antiviral use remains limited due to resistance; small trials of amantadine for post‑COVID fatigue report mixed results and require larger RCTs.
Safety signals continue to emphasise neuropsychiatric adverse events in elderly and renal impairment cohorts.
| Study | Population | Outcome | Level Of Evidence |
|---|---|---|---|
| Parkinson’s small RCTs/meta‑analyses | Idiopathic Parkinson’s patients | Modest symptomatic benefit in motor scores | Moderate |
| Drug‑Induced Parkinsonism Cohorts | Patients with antipsychotic‑related parkinsonism | Consistent improvement in extrapyramidal symptoms | Moderate |
| Post‑COVID / Fatigue Pilot Studies | Small adult cohorts | Mixed results; inconclusive | Low |
E‑E‑A‑T Note: Refer to TGA and PBS guidance plus peer‑reviewed sources when preparing patient information leaflets.
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | ATC / Use | PBS Listing | Pros / Cons |
|---|---|---|---|
| Levodopa / Carbidopa | Parkinson’s | Listed | Most effective for motor symptoms; long‑term complications include dyskinesia |
| Pramipexole / Ropinirole | Dopamine agonists | Listed | Useful as adjuncts; risk of impulse control disorders |
| Selegiline / Rasagiline | MAO‑B inhibitors | Listed | Modest benefit; fewer anticholinergic effects |
| Oseltamivir | Influenza (neuraminidase inhibitor) | Listed for certain indications | Preferred antiviral option over adamantanes due to resistance |
Pros And Cons Checklist
- Efficacy for target symptom.
- Side‑effect profile and patient comorbidities (renal, psychiatric).
- Drug interactions and polypharmacy risks.
- Cost and PBS eligibility.
- Patient preference and lifestyle impact (driving, work).
Common Questions (Australian Pharmacy FAQs)
- Q: How do I monitor for hallucinations? A: Check mood and behaviour within 2–4 weeks; stop and seek urgent care if severe hallucinations occur.
- Q: How to manage insomnia or vivid dreams? A: Advise bedtime hygiene, reduce evening caffeine/alcohol; discuss dose timing with prescriber.
- Q: What if I get dizzy on standing? A: Rise slowly, sit if lightheaded, check blood pressure; discuss dose reduction with prescriber.
- Q: Can I take OTC decongestants? A: Most are safe but check for interactions and blood pressure effects; confirm with pharmacist.
- Q: Pregnancy planning advice? A: Discuss risks and alternatives with your GP; only use if benefits outweigh risks.
Red‑flag directions: stop the drug and seek immediate care for severe hallucinations, angioedema, convulsions or severe hypotension.
Price & Access Comparison
Comparison Table — Pharmacy / Source, Typical Price Range, PBS Status
| Pharmacy / Source | Typical Private Price (AUD) | PBS Status | Prescription Required |
|---|---|---|---|
| Community Chain (e.g. Chemist Warehouse) | Varies; check in store | Depends on indication and authority | Yes |
| Independent Pharmacy | Varies | Depends | Yes |
| Online Accredited Pharmacy | Varies + delivery | Depends | Yes (e‑prescription accepted) |
Access Checklist — Urban Vs Rural Availability
- Confirm PBS authority if eligible and arrange repeats in advance.
- Plan prescriptions before travel and allow time for mail delivery.
- Rural patients: arrange scheduled mail delivery and pharmacist liaison with prescriber for urgent supply.
Registration & Regulation (TGA & PBS)
TGA Approval And Regulatory Classification
Amantadine formulations are prescription‑only with TGA governance in Australia.
Some extended‑release formulations available internationally may not be marketed locally; check ARTG for current approvals and sponsor details.
PBS Subsidy Details
PBS listings are indication‑dependent with Parkinson’s‑related uses more likely to attract subsidy than antiviral use.
- Check PBS Schedule for current listings and authority requirements.
- If special authority is needed, prescriber must submit supporting clinical information.
- Pharmacist should verify authority code before dispensing PBS‑subsidised supply.
Storage & Handling (Household & Pharmacy)
Household Storage In Australian Climate
Store tablets and capsules at room temperature between 15–30°C and protect from moisture and sunlight.
In hot or humid Australian summers keep medication in a cooler part of the home away from bathrooms.
Keep syrups tightly closed in the original container and out of reach of children.
- Use child‑resistant containers.
- Do not store in direct sunlight or near heat sources.
Pharmacy Cold‑Chain And Handling
No refrigerated storage is required; normal ambient pharmacy storage is adequate.
For mail order, use protective packaging to avoid heat spikes during transport and label clearly.
| Item | Recommended Storage |
|---|---|
| Tablets/Capsules | 15–30°C, dry, protected from light |
| Syrup | Tightly closed, original container |
Guidelines For Proper Use (Pharmacist Counselling & Patient Actions)
Australian Pharmacist Counselling Style
Confirm the indication and review renal function and concomitant medicines before supply.
Counsel on expected adverse effects: CNS effects, orthostatic hypotension and dermatologic changes such as livedo reticularis.
- Advise on driving and workplace precautions.
- Provide missed‑dose advice and explain overdose red flags.
- Document telehealth prescriptions and medication reviews.
Use a one‑page tear‑off factsheet for patients summarising dose, side effects, monitoring and emergency actions.
Patient Follow‑Up & Monitoring
Baseline renal function is recommended prior to starting therapy.
Follow up within 2–4 weeks after initiation to assess tolerance and then every 3–6 months for chronic use.
Monitor mood and behaviour, skin changes and orthostatic symptoms; record findings in a patient monitoring table.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 14-21 days |
| Newcastle | New South Wales | 14-21 days |
| Wollongong | New South Wales | 14-21 days |
| Geelong | Victoria | 14-21 days |
| Sunshine Coast | Queensland | 14-21 days |
| Townsville | Queensland | 14-21 days |
| Cairns | Queensland | 14-21 days |